KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBIT Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.56%
Dec 31, 2025 3.90%
Sep 30, 2025 -10.17%
Jun 30, 2025 45.44%
Mar 31, 2025 0.71%
Dec 31, 2024 -18.90%
Sep 30, 2024 7.92%
Jun 30, 2024 3.29%
Mar 31, 2024 -1.45%
Dec 31, 2023 27.04%
Sep 30, 2023 -6.31%
Jun 30, 2023 10.32%
Mar 31, 2023 -0.95%
Dec 31, 2022 25.29%
Sep 30, 2022 11.31%
Jun 30, 2022 4.36%
Mar 31, 2022 14.40%
Dec 31, 2021 17.00%
Sep 30, 2021 12.77%
Jun 30, 2021 119.84%
Mar 31, 2021 12.49%
Dec 31, 2020 12.17%
Sep 30, 2020 11.54%
Jun 30, 2020 17.41%
Mar 31, 2020 16.39%
Dec 31, 2019 63.07%
Sep 30, 2019 22.21%
Jun 30, 2019 17.55%
Mar 31, 2019 17.38%
Dec 31, 2018 -29.13%
Sep 30, 2018 18.17%
Jun 30, 2018 13.71%
Mar 31, 2018 17.34%
Dec 31, 2017 -0.43%
Sep 30, 2017 11.04%
Jun 30, 2017 13.36%
Mar 31, 2017 19.74%